Traditional vs Medical Device Cybersecurity (2026)

Part of our Medical device cybersecurity strategy, culture, and lifecycle series. For the full overview, start with Total Product Lifecycle Security for Devices.

Reviewed July 24, 2026

An IT response that isolates a compromised endpoint can be sensible. Applied to a medical device without clinical coordination, the same action can interrupt monitoring or treatment.

That is the practical difference we focus on. Medical device security uses familiar IT controls, but the decisions must account for clinical function, patient harm, long service lives, and evidence the FDA can review.

Why this matters

A compromised device can deliver an incorrect dose, delay treatment, or hide a change in a patient's condition. Data loss still matters. It is simply not the only consequence we assess.

The FDA's "Cybersecurity in Medical Devices" Final Guidance, dated February 3, 2026, addresses cybersecurity across the total product lifecycle, from design through postmarket surveillance. Manufacturers need more than an enterprise security policy. They need device-specific requirements, controls, testing, and a plan for maintaining deployed products.

IEC 81001-5-1 and ANSI/AAMI SW96:2023, which supplements the older AAMI TIR57, support that work through secure lifecycle activities and security risk management. Clinical usability and legacy-device constraints also shape implementation. A control that prevents unauthorized access but blocks urgent care is not an acceptable design simply because it is secure in isolation.

We treat this as an engineering problem with regulatory evidence attached, not a documentation exercise at the end of development.

At a glance

These are broad contrasts, not absolute rules. Enterprise systems can require extensive change testing and can affect safety too. For medical devices, however, clinical impact must be an explicit part of the security decision.

Understanding Traditional Cybersecurity

Traditional cybersecurity defends computers, servers, networks, applications, and data. We use many of its methods in medical device work. The difference is what those methods must protect and how we demonstrate that they work.

Definition and Importance of Traditional Cybersecurity

Traditional cybersecurity protects information systems from unauthorized access, modification, disruption, and destruction. Organizations use it to reduce data breaches, identity theft, financial loss, and operational outages.

The 2017 Equifax breach exposed personal information belonging to 147 million people. It illustrates the scale of harm an information-security failure can cause, including lasting damage to customer trust and reputation. Medical device security does not dismiss those consequences. It adds the possibility of direct clinical harm.

Core Principles of Traditional Cybersecurity

Traditional cybersecurity is built on three core principles:

• Confidentiality: Ensuring that sensitive information is accessed only by authorized individuals.
• Integrity: Protecting information from being altered or destroyed in an unauthorized manner.
• Availability: Ensuring that systems and data are accessible to authorized users when needed.

Encryption supports confidentiality. Access controls and integrity checks help prevent or detect unauthorized changes. Backups and recovery procedures support availability.

We retain all three principles for medical devices. We then ask what losing each one means for the patient. An integrity failure in a billing record and an integrity failure in a treatment command require different risk assessments.

Common Threats in Traditional Cybersecurity

Common threats include:

1. Malware: Viruses, ransomware, and other malicious software that steal data or disrupt operations.
2. Phishing: Messages that trick people into revealing information, surrendering credentials, or running malicious code.
3. DDoS attacks: Distributed denial-of-service attacks that overwhelm systems and make them unavailable.

Insiders can also cause breaches, deliberately or through mistakes. Employee training helps people recognize and report suspicious activity, but it cannot replace technical controls, monitoring, and tested recovery procedures.

These threats do not disappear at the medical device boundary. Ransomware affecting a hospital network can interrupt care even when the device itself is not infected.

Looking at Medical Device Cybersecurity

For connected medical devices, we assess the device and the systems it depends on. A companion app, home base station, update service, or cloud dashboard can create an attack path into clinical functionality.

Defining Medical Device Cybersecurity

Medical device cybersecurity protects devices used to monitor, diagnose, or treat patients, including heart monitors and surgical robots. It covers the software, hardware interfaces, communications, and supporting services that affect secure operation.

Direct internet access is not the only concern. Local wireless links, maintenance ports, and connected applications can expose a device. We scope testing around those paths rather than treating the enclosure as the entire system.

Unique Aspects of Medical Device Cybersecurity

Three constraints change the work:

• Regulatory scrutiny: Manufacturers must address applicable requirements and the expectations of agencies such as the FDA, with evidence tied to the device.
• Real-time clinical use: Access controls and incident-response actions must account for immediate patient-care needs.
• Device lifecycle management: Devices can remain in service for decades, requiring component monitoring, updates, and support planning long after release.

Manufacturers, healthcare providers, clinical engineering, and regulators have different responsibilities. Those responsibilities need to meet at clear operational boundaries: who deploys a patch, who assesses clinical impact, and who responds when support ends?

We recommend that manufacturers build security into the design phase, while authentication, update mechanisms, and failure behavior can still change.

Potential Risks in Medical Device Cybersecurity

A compromised device could deliver an incorrect drug dose, falsify patient data, or accept unauthorized remote commands. In 2019, the FDA warned about vulnerabilities in certain insulin pumps and urged patients to take protective steps.

On a Class II physiological-monitoring wearable we tested, the firmware update bootloader checked a CRC but did not verify a cryptographic signature. We modified one byte in a captured firmware image, replayed it, and the device installed the image and rebooted into modified firmware. A corruption check was being used where an authenticity check was needed.

The recommended remediation was signed firmware using ECDSA P-256, signature verification before commit, a write-protected public key, and a monotonic version counter to prevent rollback. The broader lesson is straightforward: documenting an update mechanism does not establish that only authorized firmware can run.

Connected systems can also allow an incident to spread beyond one device. Layered controls and system-level risk assessments must account for those dependencies.

Comparing Traditional Cybersecurity and Medical Device Cybersecurity

The two disciplines share tools. They differ in the consequences they evaluate, the constraints on remediation, and the evidence needed to support decisions.

Similarities Between the Two Domains

Both disciplines protect sensitive data, preserve integrity, and keep systems available. Both use firewalls, encryption, multi-factor authentication, monitoring, and software updates.

See also: What Is MedTech? MedTech vs Medical Device vs Life Sciences, CVSS Scoring for Medical Devices: A Complete Walkthrough, and Medical Device Software Development: A Compliance Guide.

Neither benefits from controls described only as aspirations. We need to know where a control operates, how it is configured, and what testing shows about its behavior.

Key Differences Highlighted

The differences become clear in three areas:

• Stakeholders: IT security remains involved, but medical device decisions also need input from manufacturers, clinical engineering, healthcare practitioners, quality, and regulatory staff.
• Risk tolerance: A business interruption and an interruption to essential treatment cannot be assessed using the same consequences alone.
• Incident response: Containment must account for the patient's current dependency on the device and the availability of alternative care.

We also separate the security effect from the patient consequence. Unauthorized access is a security outcome. Whether that access can alter therapy, suppress an alarm, or expose records determines the next part of the assessment.

Regulatory Frameworks and Compliance

Traditional cybersecurity often uses ISO/IEC 27001 or NIST frameworks to organize security governance and controls. Those frameworks remain useful, but they do not replace device-specific risk management and submission evidence.

In the United States, the FDA oversees medical devices. In Europe, EU MDR is the relevant device framework; the European Medicines Agency has roles involving certain medicine-device combinations, rather than acting as the general regulator for all medical devices.

In the FDA letters we reviewed for our September 2026 MTEC webinar, one letter raised insufficient control detail nine separate times against nine different controls in a single submission. The recurring problem was specification: passwords without a stated policy, TLS 1.2 without cipher suites, or ECDSA without a curve or hash function.

This is the part teams skip. A statement that authentication exists is not enough to evaluate it. We need a requirement, an implementation description, a test case, and a result that reviewers can trace.

Impact of Emerging Technologies

Cloud computing and the Internet of Things (IoT) expand the attack surface in both domains. Telemedicine and connected health devices also distribute clinical workflows across phones, networks, cloud services, and devices. Each dependency needs to appear in the threat model.

Across the AI-enabled devices in the letters reviewed for our September 2026 MTEC webinar, data poisoning, model inversion, and model evasion were consistently absent from the threat models. These were omissions in the reviewed sample, not a claim about all AI-enabled submissions.

Adding AI or cloud functionality therefore requires more than adding a box to an architecture diagram. We need to identify the new attack paths, their controls, and the evidence that those controls address the risks.

Implications of Differences in Cybersecurity Practices

For MedTech leaders, the practical question is where to change the development and support process. We start with risk decisions, evidence ownership, and response authority.

Impact on Risk Management Strategies

Medical device risk management must connect security failures to potential patient harm. A technical severity score alone cannot do that work.

We assess attack paths using factors such as reachability, complexity, required privileges, and user interaction. We then connect the security outcome to the device's safety assessment. Clinicians help establish what altered data, lost connectivity, or interrupted operation would mean during actual use.

Historical data, analytics, and predictive modeling can help identify emerging threats. They should inform the assessment, not substitute for examining whether an attack path exists. A lack of reported attacks does not establish that a vulnerable function is safe.

The resulting risk record should connect the threat, control, requirement, test evidence, and residual-risk decision.

Influence on Regulatory Compliance

Healthcare organizations must address general security obligations alongside device-related responsibilities. Manufacturers have separate duties for the devices they develop and maintain.

The FDA's regulatory expectations require device-specific evidence, not just a statement that the organization follows an enterprise framework. Policies, architecture views, risk assessments, testing, and labeling need to describe the same product and configuration.

We recommend assigning owners to those artifacts and reviewing them together before submission. Regular assessments and staff training help keep the process current as guidance, threats, and product designs change.

Effect on Incident Response Planning

A medical device response plan must answer questions an ordinary endpoint playbook may leave open:

• Can the device be disconnected without interrupting care?
• What clinical fallback is available?
• Who authorizes a change while the device is in use?
• How will responders preserve evidence without disrupting treatment?
• Who contacts the manufacturer and coordinates remediation?

Regular simulations and tabletop exercises can help organizations test those decisions with IT security, clinical staff, clinical engineering, and manufacturer contacts. They are planning tools, not evidence that a particular response will be safe in every clinical setting.

The goal is not simply faster containment. It is containment that reduces overall harm while keeping essential care available.

Conclusion

Medical device cybersecurity builds on traditional IT security, but it cannot stop there. Patient harm, clinical access, long service lives, and regulatory evidence change how we design controls, test them, patch products, and respond to incidents.

At Blue Goat Cyber, we focus exclusively on medical device cybersecurity. Our work supports secure development and submission activities aligned with FDA expectations, IEC 62304, and EU MDR requirements. We provide security testing and risk-management support; manufacturers retain responsibility for their product validation and regulatory decisions.

Contact us today for cybersecurity help and partner with a leader in healthcare security to build a secure future for your medical technology.

How Blue Goat approaches this

We start with the device's intended use, architecture, interfaces, and clinical dependencies. Threat modeling defines the attack paths. Security architecture reviews assess the proposed controls. Penetration testing checks whether those controls hold under attack.

Our reports connect findings to reproduction steps, patient-safety impact, risk records, and recommended remediation. Retesting checks the specific fixes rather than assuming a code change resolved the finding. We perform security testing, not the manufacturer's verification and validation program.

We align submission support with the FDA's "Cybersecurity in Medical Devices" Final Guidance and address postmarket needs such as vulnerability monitoring, disclosure processes, and update planning. The objective is evidence that engineers can act on and reviewers can follow, without promising a clearance outcome.

Visit our services at: /services/fda-premarket-cybersecurity-services.

To turn these risks into submission-ready evidence, see our medical device threat modeling service.

FAQ

What is the primary goal of medical device cybersecurity?

The primary goal is to protect patient safety and maintain clinical function. Confidentiality, integrity, and availability still matter, but we assess their loss in the context of how the device monitors or treats patients.

How does the FDA influence medical device cybersecurity?

The FDA establishes regulatory requirements and describes its expectations through premarket and postmarket guidance, including the February 3, 2026 final guidance. Manufacturers need evidence that addresses secure design, risk management, testing, and lifecycle maintenance. Guidance documents describe recommendations; applicable statutory requirements remain binding.

Why do medical devices have such long lifecycles?

Medical devices often stay in service for 10-20 years because they are expensive, complex, and embedded in patient-care workflows. That service life requires manufacturers to plan for aging components, newly discovered vulnerabilities, updates, and eventual end of support.

What unique challenges does patching present in medical device cybersecurity?

A patch must address the vulnerability without introducing unacceptable clinical risk. Manufacturers need testing and validation appropriate to the change and its impact on safety and function. Deployment also needs coordination with clinical operations. These constraints make patch planning more involved than routine automated IT updates, but they do not justify leaving vulnerabilities unmanaged.

Does medical device cybersecurity handle the same threats as traditional IT?

Yes, there is overlap, including malware, ransomware, and stolen credentials. Medical device testing must also address attacks against clinical functions, telemetry, wireless interfaces, and firmware updates. The same attack technique can have a different consequence when it affects treatment or monitoring.

Can a cyberattack on a medical device cause physical harm?

Yes. An attack could alter drug delivery, falsify patient data, suppress an alarm, or interrupt treatment, potentially causing injury or death. The risk depends on the device, the reachable attack path, and the clinical situation. We assess those specifics rather than assuming every vulnerability has the same patient impact.

More on this topic

• Why Hooded Hackers Hurt Medical Device
• Ephemeral Ports in Medical Device
• Enhancing Medical Device Security: Tamper